Fol. Biol. 2007, 53, 27-32
https://doi.org/10.14712/fb2007053010027
The Influence of Three Endothelin-1 Polymorphisms on the Progression of IgA Nephropathy
References
1. 2004) Pathogenesis of IgA nephropathy. Semin. Nephrol. 24, 197-217.
< , J., Feehally, J., Smith, A. C. (https://doi.org/10.1016/j.semnephrol.2004.01.002>
2. 2001) Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am. J. Kidney Dis. 37, 720-727.
< , F., Deprele, C., Sassolas, A., Moulin, P., Alamartine, E., Berthezene, F., Berthoux, F. (https://doi.org/10.1016/S0272-6386(01)80120-7>
3. 2003) Beta1-3-galactosyltransferase activity in IgA nephropathy. J. Am. Soc. Nephrol. 14, 632A.
, K. S., Barratt, J., Feehally, J., Smith, A. C. (
4. 2000) IgA nephropathy: Recent developments. J. Am. Soc. Nephrol. 11, 2395-2403.
< , J., Feehally, J. (https://doi.org/10.1681/ASN.V11122395>
5. 2000) IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat. Genet. 26, 354-357.
< , A. G., Yan, Y., Scolari, F. (https://doi.org/10.1038/81677>
6. 2002) A(-20)C polymorphism of the angiotensinogen gene and progression of IgA nephropathy. Kidney Int. 62, 980-985.
< , S., Narita, I., Saito, N.,Watanabe, Y., Yamazaki, H., Sakatsume, M., Shimada, H., Nishi, S., Ueno, M., Akazawa, K., Arakawa, M., Gejyo, F. (https://doi.org/10.1046/j.1523-1755.2002.00517.x>
7. 1999) Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J. Am. Soc. Nephrol. 10, 760-769.
< , Y., Kokubo, T., Iwase, H. (https://doi.org/10.1681/ASN.V104760>
8. 2003) Association of endothelin-1 gene variant with hypertension. Hypertension 41, 163-167.
< , J. J., Nakura, J., Wu, Z., Yamamoto, M., Abe, M., Tabara, Y. (https://doi.org/10.1161/01.HYP.0000043680.75107.CF>
9. 1999) Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am. J. Kidney Dis. 33, 225-34.
< , R. J., Kivlighn, S. D., Kim, Y. G., Suga, S., Fogo, A. B. (https://doi.org/10.1016/S0272-6386(99)70295-7>
10. 2003) IgA nephropathy and Henoch-Schonlein nephritis. Clin. Nephrol. 24, 319-329.
, J. R., Feehally, J. (
11. 1999) Exposed peptide core of IgA1 hinge region in IgA nephropathy. Nephrol. Dial. Transplant. 14, 81-85.
< , T., Hiki, Y., Iwase, H. (https://doi.org/10.1093/ndt/14.1.81>
12. 2000) Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy. Nephrol. Dial. Transplant. 15, 28-33.
< , T., Hashizume, K., Iwase, H. (https://doi.org/10.1093/ndt/15.1.28>
13. 2001) Endothelin gene variants and aortic and cardiac structure in never-treated hypertensives. Am. J. Hypertens. 14, 755-760.
< , M., Gautier, S., Poirier, O. (https://doi.org/10.1016/S0895-7061(01)02162-8>
14. 1999) Increased sialylation of polymeric immunoglobulin A1: Mechanism of selective glomerular deposition in immunoglobulin A nephropathy? J. Lab. Clin. Med. 133, 152-160.
, J. C. K., Poon, P. Y. K., Lai, K. N. (
15. 2003) IgA nephropathy: A family affair. Nephrology Rounds 4, 1.
, R., Pei, Y. (
16. 1993) Defective galactosylation and clearance of IgA 1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib. Nephrol. 104, 172-182.
< , J., Tomana, M., Crowley-Nowick, P. A., Moldoveanu, Z., Julian, B. A., Jackson, S. (https://doi.org/10.1159/000422410>
17. 2002) Pathogenic potential of galactose-deficient IgA1 in IgA nephropathy. Nephrology 7, S92-S99.
< , J., Novak, J., Julian, B. A.(https://doi.org/10.1046/j.1440-1797.7.s3.3.x>
18. 2003a) Angiotensinogen gene variation and renoprotective efficacy of renin-angiotensin system blockade in IgA nephropathy. Kidney Int. 64, 1050-1058.
< , I., Goto, S., Saito, N., Song, J., Omori, K., Kondo, D., Sakatsume, M., Gejyo, F. (https://doi.org/10.1046/j.1523-1755.2003.00187.x>
19. 2003b) Interaction between ACE and ADD1 gene polymorphisms in the progression of IgA nephropathy in Japanese patients. Hypertension 42, 304-309.
< , I., Goto, S., Saito, N., Song, J., Ajiro, J., Sato, F., Saga, D., Kondo, D., Akazawa, K., Sakatsume, M., Gejyo, F. (https://doi.org/10.1161/01.HYP.0000085193.25617.78>
20. 2002) Interactions of human mesangial cells with IgA and IgA-containing circulating immune complexes. Kidney Int. 62, 465-475.
< , J., Vu, H. L., Novak, L. (https://doi.org/10.1046/j.1523-1755.2002.00477.x>
21. 2005) IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int. 67, 504-513.
< , J., Tomana, M., Matousovic, K. (https://doi.org/10.1111/j.1523-1755.2005.67107.x>
22. 2003) Role of the endothelin-1 gene locus for renal impairment in the general nondiabetic population. J. Am. Soc. Nephrol. 14, 2596-2602.
< , S. J., Hermann, S. M., Schmidt-Peterson, K., Niu, T. (https://doi.org/10.1097/01.ASN.0000089827.03201.8E>
23. 2002) Increased risk of end-stage renal disease in familial IgA nephropathy. J. Am. Soc. Nephrol. 13, 453-460.
< , F. P., Cerullo, G., Rossini, M., Lanzilotta, S. G., D´Altri, Ch., Manno, C. (https://doi.org/10.1681/ASN.V132453>
24. 2003) Inherited forms of IgA nephropathy. J. Nephrol. 16, 317-320.
, F. (
25. 2003) Peroxisome proliferator-activated receptor gamma C161T polymorphisms and survival of Japanese patients with immunoglobulin A nephropathy. Clin. Genet. 64, 398-403.
< , J., Sakatsume, M., Narita, I., Goto, S., Omori, K., Takada, T., Saito, N., Ueno, M., Gejyo, F. (https://doi.org/10.1034/j.1399-0004.2003.00154.x>
26. 2005) Genomewide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22-23. J. Am. Soc. Nephrol. 16, 1289-1299.
< , H., Suzuki, Y., Yamanaka, T., Hirose, S., Nishimura, H., Toei, J., Horikoshi, S., Tomino, Y. (https://doi.org/10.1681/ASN.2004030219>
27. 2000) Angiotensin-converting enzyme insertion/deletion polymorphism and prognosis of IgA nephropathy. Nephron 86, 115-121.
< , J., Huang, X. H., Mustonen, J., Koivula, T., Lehtimaki, T., Pasternack, A. (https://doi.org/10.1159/000045728>
28. 2000) Hypertriglyceridemia and hyperuricemia are risk factors for progression of IgA nephropathy. Nephrol. Dial. Transplant. 15, 34-42.
< , J., Mustonen, J., Pasternack, A. (https://doi.org/10.1093/ndt/15.1.34>
29. 2004) Evaluation of the Lys198Asn and -134delA genetic polymorphisms of the endothelin-1 gene. Hypertens. Res. 27, 367-371.
, C. H., Kamide, K., Takiuchi, S., Kawano, Y., Miyata, T. (
30. 1999) The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 33, 1169-1174.
< , L., Poirier, O., Hallet, V., McDonagh, T. A., Morrison, C., McMurray, J. J., Dargie, H. J., Arveiler, D., Ruidavets, J. B., Luc, G., Evans, A., Cambien, F. (https://doi.org/10.1161/01.HYP.33.5.1169>
31. 1997) Galactosedeficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int. 52, 509-516.
< , M., Matousovic, K., Julian, B. A. (https://doi.org/10.1038/ki.1997.361>
32. 1999) Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J. Clin. Invest. 104, 73-81.
< , M., Novak, J., Julian, B. A. (https://doi.org/10.1172/JCI5535>